Literature DB >> 1657379

Effect of different tumor types on resting energy expenditure.

E W Fredrix1, P B Soeters, E F Wouters, I M Deerenberg, M F von Meyenfeldt, W H Saris.   

Abstract

The purpose of this study was to investigate whether the presence of a malignant tumor influences energy metabolism of the host. Resting energy expenditure (REE) was measured in 104 gastric and colorectal (GCR) cancer patients and in 47 non-small cell lung cancer patients and was compared with REE values in 40 healthy controls. REE expressed per kilogram of fat-free mass (FFM) in lung cancer patients was elevated, in comparison with healthy controls (33.6 +/- 4.6 and 29.6 +/- 2.9 kcal, respectively; P less than 0.001), in contrast to REE/FFM in GCR cancer patients, which showed no difference, compared with these controls (29.8 +/- 4.3 kcal). In 47 patients with GCR cancer and in 14 patients with lung cancer, REE was also determined after tumor resection. REE in GCR cancer patients measured 1.5 years after tumor resection showed a small but significant increase. No differences were observed between GCR cancer patients with or without signs of tumor recurrence. REE in lung cancer patients with no signs of tumor recurrence measured 1 year after tumor resection had a significant decrease in REE (REE/FFM, -6.8%; P less than 0.05), while patients who had evidence of tumor recurrence showed no change in REE or even an increase. After curative surgery REE returned to a normal level in the lung cancer patients. These results suggest that tumor type is a major determinant of an increased energy expenditure in cancer patients.

Entities:  

Mesh:

Year:  1991        PMID: 1657379

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Total energy expenditure in patients with colorectal cancer: associations with body composition, physical activity, and energy recommendations.

Authors:  Sarah A Purcell; Sarah A Elliott; Peter J Walter; Tom Preston; Hongyi Cai; Richard J E Skipworth; Michael B Sawyer; Carla M Prado
Journal:  Am J Clin Nutr       Date:  2019-08-01       Impact factor: 7.045

Review 2.  Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review.

Authors:  Benjamin H L Tan; James A Ross; Stein Kaasa; Frank Skorpen; Kenneth C H Fearon
Journal:  J Genet       Date:  2011-04       Impact factor: 1.166

Review 3.  Cancer cachexia, mechanism and treatment.

Authors:  Tomoyoshi Aoyagi; Krista P Terracina; Ali Raza; Hisahiro Matsubara; Kazuaki Takabe
Journal:  World J Gastrointest Oncol       Date:  2015-04-15

4.  Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.

Authors:  J S Falconer; K C Fearon; C E Plester; J A Ross; D C Carter
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

5.  The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia.

Authors:  Federica Calore; Priya Londhe; Paolo Fadda; Giovanni Nigita; Lucia Casadei; Gioacchino Paolo Marceca; Matteo Fassan; Francesca Lovat; Pierluigi Gasparini; Lara Rizzotto; Nicola Zanesi; Devine Jackson; Svasti Mehta; Patrick Nana-Sinkam; Deepa Sampath; Raphael E Pollock; Denis C Guttridge; Carlo M Croce
Journal:  Cancer Res       Date:  2018-09-12       Impact factor: 12.701

6.  [Diagnosis of and therapy for hepatocellular carcinoma].

Authors:  T F Greten; N P Malek; S Schmidt; J Arends; P Bartenstein; W Bechstein; T Bernatik; M Bitzer; A Chavan; M Dollinger; D Domagk; O Drognitz; M Düx; S Farkas; G Folprecht; P Galle; M Geißler; G Gerken; D Habermehl; T Helmberger; K Herfarth; R T Hoffmann; M Holtmann; P Huppert; T Jakobs; M Keller; J Klempnauer; F Kolligs; J Körber; H Lang; F Lehner; F Lordick; A Lubienski; M P Manns; A Mahnken; M Möhler; C Mönch; P Neuhaus; C Niederau; M Ocker; G Otto; P Pereira; G Pott; J Riemer; K Ringe; U Ritterbusch; E Rummeny; P Schirmacher; H J Schlitt; K Schlottmann; V Schmitz; A Schuler; H Schulze-Bergkamen; D von Schweinitz; D Seehofer; H Sitter; C P Straßburg; C Stroszczynski; D Strobel; A Tannapfel; J Trojan; I van Thiel; A Vogel; F Wacker; H Wedemeyer; H Wege; A Weinmann; C Wittekind; B Wörmann; C J Zech
Journal:  Z Gastroenterol       Date:  2013-11-15       Impact factor: 2.000

7.  Day-night pattern of energy expenditure and body temperature in cachectic tumour-bearing rats.

Authors:  H Oudart; A Malan; Y Maho; A Geloen
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

Review 8.  Non-surgical oncology - Guidelines on Parenteral Nutrition, Chapter 19.

Authors:  J Arends; G Zuercher; A Dossett; R Fietkau; M Hug; I Schmid; E Shang; A Zander
Journal:  Ger Med Sci       Date:  2009-11-18

9.  Microencapsulated Bifidobacterium bifidum and Lactobacillus gasseri in Combination with Quercetin Inhibit Colorectal Cancer Development in ApcMin/+ Mice.

Authors:  Iván Benito; Ignacio J Encío; Fermín I Milagro; María Alfaro; Ana Martínez-Peñuela; Miguel Barajas; Florencio Marzo
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

10.  Cancer cachexia: impact, mechanisms and emerging treatments.

Authors:  Vanessa C Vaughan; Peter Martin; Paul A Lewandowski
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-10-25       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.